SEC Tracker
Get the app

Chemomab Therapeutics CMMB

Chemomab Therapeutics: Ownership stake disclosure

Schedule 13D on Chemomab Therapeutics (CMMB), filed with the SEC on Nov 10, 2026, 5:30 pm ET. Source: the filing on SEC EDGAR.

Ownership stake disclosure by Scipher Medicine Corp

Form
Schedule 13D
Filed
Importance
Notable
  1. Scipher purchased 932,203 ADSs for $1.18 per ADS, totaling $1,100,000.
  2. Funding came from $858,612 in Notes and $241,387 in working capital.
  3. Notes mature on August 5, 2027, and rank senior to other Scipher debt.
  4. Investors included Don Gogel, Khosla Ventures, and Northpond Capital.

Written from the Schedule 13D on EDGAR. AI can make mistakes. Check the filing.

Get the appView on EDGAR

Get an email when Chemomab Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Data on this page was fetched . The filing on SEC.gov is the record.